Brown Advisory’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.09M Hold
10,389
﹤0.01% 668
2025
Q4
$2.15M Sell
10,389
-100
-1% -$20K ﹤0.01% 663
2025
Q3
$1.88M Hold
10,489
﹤0.01% 680
2025
Q2
$1.69M Hold
10,489
﹤0.01% 685
2025
Q1
$1.78M Sell
10,489
-400
-4% -$69.5K ﹤0.01% 652
2024
Q4
$1.81M Sell
10,889
-711
-6% -$121K ﹤0.01% 670
2024
Q3
$1.99M Buy
11,600
+111
+1% +$18.4K ﹤0.01% 645
2024
Q2
$1.77M Sell
11,489
-165
-1% -$24.8K ﹤0.01% 654
2024
Q1
$1.79M Sell
11,654
-331
-3% -$50.5K ﹤0.01% 661
2023
Q4
$1.89M Sell
11,985
-304
-2% -$43.7K ﹤0.01% 633
2023
Q3
$1.8M Sell
12,289
-270
-2% -$41.1K ﹤0.01% 627
2023
Q2
$1.92M Sell
12,559
-355
-3% -$55.4K ﹤0.01% 621
2023
Q1
$2M Buy
12,914
+186
+1% +$29.2K ﹤0.01% 611
2022
Q4
$1.96M Buy
12,728
+4,374
+52% +$645K ﹤0.01% 617
2022
Q3
$1.1M Buy
8,354
+2,850
+52% +$400K ﹤0.01% 690
2022
Q2
$746K Buy
5,504
+1,700
+45% +$234K ﹤0.01% 757
2022
Q1
$567K Buy
3,804
+2,025
+114% +$300K ﹤0.01% 828
2021
Q4
$288K Buy
+1,779
New +$288K ﹤0.01% 1047
2016
Q1
Sell
-1,844
Closed -$208K 1003
2015
Q4
$208K Buy
+1,844
New +$199K ﹤0.01% 897
2015
Q3
Sell
-2,055
Closed -$255K 941
2015
Q2
$255K Hold
2,055
﹤0.01% 763
2015
Q1
$243K Hold
2,055
﹤0.01% 845
2014
Q4
$210K Sell
2,055
-2,553
-55% -$249K ﹤0.01% 873
2014
Q3
$423K Hold
4,608
﹤0.01% 700
2014
Q2
$379K Buy
+4,608
New +$352K ﹤0.01% 741

Other funds holding FBT

Brown Advisory's FBT Position: Q1 2026 in Review

Brown Advisory held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 10,389 shares worth $2.09M. The position accounts for ﹤0.01% of the portfolio, ranked #668.

Brown Advisory first reported a position in FBT in Q2 2014 and has held it in 24 quarters since. The position peaked at $2.15M in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Brown Advisory held 10,389 shares of First Trust NYSE Arca Biotechnology Index Fund worth $2.09M as of Q1 2026.
  • Brown Advisory left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Brown Advisory's portfolio in Q1 2026, its #668 holding.
  • Brown Advisory first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2014 and has held it in 24 quarters since.
  • Brown Advisory's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.15M in Q4 2025.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.